Role of Ras Inhibitors in the Management of Breast Cancer

Reviewer: Christopher Dolinsky, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 7 de noviembre del 2005

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Circulating Tumor Cell Assays May Play Role in Managing Bladder CA

Aug 25, 2015

IsoFlux test showed 10 or more circulating tumor cells in four of nine samples, versus 0 with CellSearch

Hedgehog Pathway Key in Tamoxifen-Resistant Breast CA

Nov 7, 2012

Elements of Hh signaling pathway protected from proteasomal degradation by PI3K/AKT pathway

Extended RAS Testing Urged Before EGFR MoAB Therapy

Oct 8, 2015

Extended testing recommended for mutations in KRAS, NRAS in patients with metastatic CRC